(Q28292277)

English

Hexamethylmelamine and Low or Moderate Dose Cisplatin With or Without Pyridoxine for Treatment of Advanced Ovarian Carcinoma: A Study of the Eastern Cooperative Oncology Group

scientific article published on January 1, 1992

In more languages

Statements

scholarly article

0 references

Hexamethylmelamine and low or moderate dose cisplatin with or without pyridoxine for treatment of advanced ovarian carcinoma: a study of the Eastern Cooperative Oncology Group (English)

0 references

Hexamethylmelamine and Low or Moderate Dose Cisplatin With or Without Pyridoxine for Treatment of Advanced Ovarian Carcinoma: A Study of the Eastern Cooperative Oncology Group (English)

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

ovarian carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Peter H. Wiernik

1

object named as

P H Wiernik

0 references

author name string

B. Yeap

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

S. E. Vogl

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

B. H. Kaplan

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

R. L. Comis

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

G. Falkson

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

T. E. Davis

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

E. Fazzini

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

B. Cheuvart

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

J. Horton

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735009

11 November 2022

language of work or name

0 references

publication date

1992

0 references

full work available at URL

http://www.tandfonline.com/doi/pdf/10.3109/07357909209032783

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer Investigation

0 references

10

0 references

1

0 references

1-9

0 references

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.3109/07357909209032783

20 April 2017

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

Exact significance testing to establish treatment equivalence with ordered categorical data

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

High-dose platinum for the treatment of refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

High-dose cisplatin in hypertonic saline in refractory ovarian cancer

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

Ten-year follow-up of patients receiving cisplatin, doxorubicin, and cyclophosphamide chemotherapy for advanced epithelial ovarian carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

Chemotherapeutic and surgical induction of pathological complete remission and whole abdominal irradiation for consolidation does not enhance the cure of stage III ovarian carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

Predictability of the survival of patients with advanced ovarian cancer.

1 reference

https://api.crossref.org/works/10.3109%2F07357909209032783

21 January 2018

Long-term results of a cisplatin-containing combination chemotherapy regimen for the treatment of advanced ovarian carcinoma

1

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer Treatment Reports

2

63

1539

author name string

Young R C

publication date

1979

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer Treatment Reports

3

70

1003

author name string

Foster B J

publication date

1986

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

4

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer Treatment Reports

5

66

1285

author name string

Vogl S E

publication date

1982

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer Treatment Reports

6

63

1359

author name string

Fabian C J

publication date

1979

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Cancer chemotherapy reports

12

50

163

author name string

Mantel N

publication date

1966

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Use of high dose cis-dichlorodiammine platinum (II) (NSC--119875) following failure on previous chemotherapy for advanced carcinoma of the ovary

15

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Advanced ovarian cancer: long-term results of treatment with intensive cisplatin-based chemotherapy of brief duration

19

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

The impact of aggressive debulking surgery and cisplatin-based chemotherapy on progression-free survival in stage III and IV ovarian carcinoma

20

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Randomized trial of cyclophosphamide plus cisplatin with or without doxorubicin in ovarian carcinoma: a Gynecologic Oncology Group Study

21

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Journal of the American Medical Association

24

241

author name string

Vogl S E

publication date

1908

1 reference

10.3109/07357909209032783

https://api.crossref.org/works/10.3109/07357909209032783

11 November 2022

Identifiers

10.3109/07357909209032783

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28292277&oldid=1769556240"